Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
-11.22% | -24.86% |
Jul. 01 | Harte Hanks, Inc.(NasdaqGM:HHS) dropped from Russell Microcap Value Index | CI |
Jul. 01 | Harte Hanks, Inc.(NasdaqGM:HHS) dropped from Russell 3000E Value Index | CI |
Financials (USD)
Sales 2024 * | 194M | Sales 2025 * | 202M | Capitalization | 63.14M |
---|---|---|---|---|---|
Net income 2024 * | 5M | Net income 2025 * | 10M | EV / Sales 2024 * | 0.22 x |
Net cash position 2024 * | 20M | Net cash position 2025 * | 27.2M | EV / Sales 2025 * | 0.18 x |
P/E ratio 2024 * |
11.3
x | P/E ratio 2025 * |
6.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.54% |
Latest transcript on Harte Hanks, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Kirk Davis
CEO | Chief Executive Officer | 62 | 23-06-18 |
David Garrison
DFI | Director of Finance/CFO | 55 | 23-10-22 |
Elliott Peterson
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Griffin
CHM | Chairman | 63 | 18-07-04 |
Bradley Radoff
BRD | Director/Board Member | 50 | 21-05-16 |
Genevieve Combes
BRD | Director/Board Member | 57 | 21-05-16 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.55% | 2.25B | |
-32.55% | 459M | |
-27.82% | 383M | |
-6.94% | 134M | |
-49.23% | 112M | |
+4.67% | 107M | |
+71.70% | 92.12M | |
+6.48% | 86.05M | |
+20.00% | 68.23M |
- Stock Market
- Equities
- HHS Stock
- HRTH Stock